TEAD4 and breast cancer: Public bioinformatics analysis showed that TEAD4, rather than TEAD1-3, was dramatically transcribed among the TEADs family members (Fig. S3C) and was positively correlated with poor prognosis in patients with breast cancer (Fig. S3D).